Dual Bclxl and BCL2 Inhibition with Navitoclax (NAV), Venetoclax (VEN), and Decitabine (DEC) for Advanced Myeloid Neoplasms (MN): Safety and Biological Activity in a Phase 1 Study by Chen, Evan C., Liu, Yiwen, Bell, Hayden L., Galinsky, Ilene A., Luskin, Marlise R., Winer, Eric S., Stahl, Maximilian, Vedula, Rahul, Volpe, Virginia O., DeAngelo, Daniel J., Quillen, Karen, Ryan, Jeremy, Minihane, Emma-Jayne, Hersch, Matthew, Leonard, Rebecca, Neuberg, Donna S., Stone, Richard M., Letai, Anthony G., Lane, Andrew A., Garcia, Jacqueline S.

Get full text